Longitudinal anthropometric study in children with acute lymphoblastic leukaemia

Acta Paediatr. 1992 Jan;81(1):61-5. doi: 10.1111/j.1651-2227.1992.tb12080.x.

Abstract

In four groups of patients with acute lymphoblastic leukaemia, anthropometric variables were investigated every 3 months for 2 years. Group 1 (n = 7) was treated with a high-risk protocol, group 2 (n = 13) with a standard-risk protocol including cranial irradiation, group 3 (n = 13) with a standard-risk protocol without cranial irradiation and group 4 (n = 8) was followed after completion of treatment. A height retardation of 0.4-0.6 SD was observed during therapy in groups 1-3. A catch-up of 0.5 SD was found in group 4. The retardation of armspan was significantly larger than the retardation of sitting height when groups 1-3 were taken together. Head circumference was not affected. The anthropometric variables reflecting nutritional status showed a growth above normal during and after treatment. Corticosteroid medication and not cranial irradiation is the most likely explanation for our findings.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • Anthropometry
  • Antineoplastic Agents / adverse effects*
  • Body Height / drug effects
  • Body Height / radiation effects
  • Child
  • Combined Modality Therapy
  • Cranial Irradiation / adverse effects*
  • Cranial Irradiation / statistics & numerical data
  • Female
  • Growth / drug effects*
  • Growth / radiation effects
  • Humans
  • Longitudinal Studies
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / radiotherapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Prospective Studies
  • Risk Factors

Substances

  • Adrenal Cortex Hormones
  • Antineoplastic Agents